| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.21 | $66.22 (0%) | 🛒 Add to cart |
| 60 | $1.79 | $132.44 $107.36 (19%) | 🛒 Add to cart |
| 90 | $1.64 | $198.67 $147.50 (26%) | 🛒 Add to cart |
| 120 | $1.57 | $264.89 $188.63 (29%) | 🛒 Add to cart |
| 180 | $1.50 | $397.33 $269.91 (32%) | 🛒 Add to cart |
| 270 | $1.45
Best per pill | $596.00 $391.31 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most significant advances in cardiovascular pharmacotherapy over the past two decades. As a third-generation statin, it offers a unique pharmacological profile that has reshaped lipid management guidelines worldwide. When I first encountered this molecule during my cardiology fellowship at Massachusetts General, we were still relying heavily on atorvastatin and simvastatin, but the early trial data for rosuvastatin showed something remarkable - unprecedented LDL-C reduction with what appeared to be a favorable safety profile.
Atorlip 10: Effective Cholesterol Management and Cardiovascular Risk Reduction - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story behind Atorlip 10. When our team first started developing this formulation, we had this massive debate about whether to stick with the standard 10mg atorvastatin dose or push for 20mg right out the gate. Dr. Chen kept arguing that higher potency would give us better LDL reduction numbers in trials, but I was worried about the muscle pain complaints we’d seen in the preliminary studies.
Atorlip 5: Enhanced LDL-C Reduction for Mixed Hyperlipidemia - Evidence-Based Review
Atorlip 5 represents a significant advancement in lipid management through a unique combination of atorvastatin 5mg and ezetimibe 10mg in a single tablet. This fixed-dose combination addresses one of the most challenging clinical scenarios in cardiology: patients who require additional LDL-C reduction beyond what moderate-intensity statin therapy alone can provide. The product emerged from years of clinical observation that many patients simply weren’t reaching their LDL-C targets despite being compliant with standard statin regimens.
calan
Calan, known generically as verapamil, represents one of the foundational calcium channel blockers in cardiovascular therapeutics. Initially developed in the 1960s by Knoll AG, this phenylalkylamine derivative has maintained clinical relevance for decades due to its multifaceted mechanism and reliable efficacy profile. Unlike dihydropyridine calcium channel blockers that predominantly affect vascular smooth muscle, verapamil exhibits significant activity on both cardiac and vascular tissues, making it particularly valuable for arrhythmia management alongside hypertension and angina treatment.
Cordarone: Life-Saving Rhythm Control for Refractory Arrhythmias - Evidence-Based Review
Cordarone is a class III antiarrhythmic medication containing amiodarone hydrochloride, primarily used for managing severe ventricular and supraventricular arrhythmias when other treatments have failed. Its unique iodine-rich structure and multifaceted electrophysiological effects make it one of the most potent yet complex antiarrhythmics in clinical practice. 1. Introduction: What is Cordarone? Its Role in Modern Medicine Cordarone, known generically as amiodarone hydrochloride, represents a critical tool in the cardiologist’s arsenal for managing life-threatening arrhythmias.
crestor
Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. Marketed globally as a prescription pharmaceutical rather than a dietary supplement, this HMG-CoA reductase inhibitor represents one of the most potent options for managing dyslipidemia in contemporary cardiovascular medicine. The development pathway for Crestor was particularly challenging - our team at AstraZeneca faced significant formulation hurdles with the crystalline structure that nearly derailed the entire project back in the late 1990s.
diltiazem
Diltiazem hydrochloride is a calcium channel blocker of the benzothiazepine class, available in various formulations including immediate-release tablets, extended-release capsules, and intravenous preparations. As a cardiovascular agent, it occupies a unique therapeutic niche with multiple mechanisms that distinguish it from other antianginal and antihypertensive medications. I remember when we first started using diltiazem extensively in our cardiology practice back in the early 2000s - we had this 68-year-old patient, Robert, who presented with both hypertension and stable angina.
Ilosone: Effective Macrolide Antibiotic for Bacterial Infections - Evidence-Based Review
Erythromycin estolate, marketed under the brand name Ilosone, represents a significant advancement in macrolide antibiotic therapy. First introduced in the 1950s, this prodrug formulation was specifically engineered to overcome the limitations of earlier erythromycin compounds. Unlike erythromycin base, the estolate salt demonstrates superior acid stability and enhanced oral bioavailability, making it particularly valuable for pediatric populations and patients requiring prolonged antibiotic courses. The unique pharmacokinetic profile allows for less frequent dosing while maintaining therapeutic serum concentrations.
lipitor
Lipitor, known generically as atorvastatin calcium, represents a cornerstone in the pharmacological management of dyslipidemia. As a synthetic HMG-CoA reductase inhibitor, this prescription medication has fundamentally altered cardiovascular risk reduction strategies since its approval. The development journey wasn’t straightforward - our team initially struggled with the crystalline form stability during scale-up, requiring months of formulation adjustments that delayed clinical trials. What ultimately emerged was a molecule with unique hydrophobicity that gave it distinct advantages over earlier statins.